NEW YORK (GenomeWeb) – Waters reported today that its first quarter revenues rose 5 percent year over year, driven by strong demand for the company's products from the pharmaceutical industry.

The company posted revenues of $498 million for the quarter, compared to $475.2 million in Q1 2016, beating the average Wall Street estimate of $488.6 million.

Currency translation reduced sales growth by around 1 percent, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.